A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model
PAI-1 的强效抑制剂 MDI-2517 可减轻临床前系统性硬化症模型中的疾病严重程度。
期刊:JCI Insight
影响因子:6.1
doi:10.1172/jci.insight.195005
Su, Enming J; Tsou, Pei-Suen; Warnock, Mark; Subbotina, Natalya; Mann, Kris; Vichaikul, Sirapa; Rosek, Alyssa; Leung, Lisa; Xing, Xianying; Xing, Enze; Plazyo, Olesya; Bogle, Rachael; Tsoi, Lam C; Emal, Cory D; Khanna, Dinesh; Varga, John; Sisson, Thomas H; Gudjonsson, Johann E; Lawrence, Daniel A